Trial Profile
A Phase 1, Open-Label, Drug-Drug Interaction Study Between Methadone and BMS-663068; and Between Buprenorphine/Naloxone and BMS-663068
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Jul 2023
Price :
$35
*
At a glance
- Drugs Fostemsavir (Primary) ; Buprenorphine/naloxone; Methadone
- Indications Cancer pain; Opioid-related disorders
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 13 Apr 2019 Results published in the British Journal of Clinical Pharmacology
- 26 Jul 2017 Results presented at the 9th International AIDS Society Conference on HIV Science
- 18 Jul 2016 Status changed from recruiting to completed.